Session: L7-1-Accomplishments and Controversies in Cancer Prevention and Control
Supported by Genzyme, a Sanofi company
Hall D (Moscone Center)
There has been significant progress in the "war on cancer." Indeed there has been a 20% decrease in age adjusted mortality over the past twenty years. Despite this there is still significant controversy about the usefulness of certain screening technologies especially for thyroid, breast and prostate cancer. There are also concerns regarding the effectiveness of certain treatments and prevention technologies.
See more of: Plenary